The Pharmacology of Nonprescription Medications

  • Norman S. Miller


Over-the-counter medications (OTC) are defined as proprietary medications or drugs sold “over the counter” in stores, such as pharmacies, grocery stores, etc. These drugs do not require prescriptions for purchase and are often not used as a result of a recommendation of a physician. The motivation for use is often self-determined for common ailments that may or may not require the attention of a physician.


Nicotinic Acid Withdrawal Syndrome Megaloblastic Anemia Acanthosis Nigricans Alcohol Withdrawal Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Pepper GA (1986). Rational use of OTCs. Nurse Pract2:00–00.Google Scholar
  2. 2.
    Esmay JB, Wertheimer AI (1979). A review of over-the-counter drug therapy./Community Health5 (l): 00–00.Google Scholar
  3. 3.
    Tolbert RB (1987). Health professionals should monitor workers’ over-the-counter drug use. Occup Health & Saf56:52–54.Google Scholar
  4. 4.
    Shands VP, Goff LD, Goff DH (1983). Rx for OTC users: Improved health education J Occup Saf Health53 (7): 423–426.Google Scholar
  5. 5.
    Anon (1984). What patients know about OTC limits. RN47:75–82.Google Scholar
  6. 6.
    Rodman MJ (1981). The drug interactions we overlook. RN44:37–41.Google Scholar
  7. 7.
    Lamy PP (1982). Over-the-counter medication: The drug interactions we overlook. J Am GeriatrSoc30 (11; Suppl.): 569–575.Google Scholar
  8. 8.
    Ovesen L (1984). Vitamin therapy in the absence of obvious deficiency: What is the evidence. Drugs27:148–170.PubMedCrossRefGoogle Scholar
  9. 9.
    Alhadeff L, Gualtieri CT, Lipton M (1984). Toxic effects of water-soluble vitamins. Nutr Rev42 (2): 34–40.Google Scholar
  10. 10.
    Bravo EL (1988). Phenylpropanolamine and other over-the-counter vasoaction compounds. Hypertension2:117–1110.Google Scholar
  11. 11.
    Pentel D (1984). Toxicity of over-the-counter stimulants. JAMA252 (14): 1898–1903.PubMedCrossRefGoogle Scholar
  12. 12.
    Vener AM, Krupka LR, Cluno JJ (1982). Drugs (prescription, over-the-counter, social) and the young addict: Use and attitudes. Int J Addict17 (3): 399–415.PubMedGoogle Scholar
  13. 13.
    Spencer R, Alexander D (1986). Clients regarding over-the-counter drug use. J Community Health Nurs3 (l): 3–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Kofoed LL (1985). OTC drug overuse on the elderly: What to watch for. Geriat–rics40 (10): 55–60.Google Scholar
  15. 15.
    Disauer SC, Greden JF, Snider RM (1987). Antidepressant withdrawal syndromes: Phenomenology and pathophysiology. Int J Clin Psychopharmacol2:1–19.CrossRefGoogle Scholar
  16. 16.
    Grahn JL (1983). Relationship of consumers’ perceptions of drugs to drug use. Public Health Rep98 (l): 85–90.PubMedGoogle Scholar
  17. 17.
    Vener AM, Krupka LR (1986). Over-the-counter drug advertising in gender-oriented popular magazines. JDrugEduc16 (4): 367–381.PubMedCrossRefGoogle Scholar
  18. 18.
    Dangor CM, Veltman (1985). Ethanol content of some pharmaceuticals available in the RS A. SAm Med768:172–173.Google Scholar

Copyright information

© Springer-Verlag New York 1991

Authors and Affiliations

  • Norman S. Miller
    • 1
  1. 1.Cornell University Medical CollegeNew York Hospital-Cornell Medical CenterUSA

Personalised recommendations